Maitreyee Panda

2 months ago | onlinelibrary.wiley.com | Rahul Mahajan |Rashmi Sarkar |Maitreyee Panda |Bhumesh Kumar Katakam

Background Atopic dermatitis (AD) is the most common inflammatory skin disease in the pediatric age group, affecting 15%–20% of children globally. Initial treatment modes include hydration, occlusive topical medicines, antimicrobial treatment, phototherapy, and systemic immune suppressants in the case of severe to moderate refractory AD. However, there is a lack of head-to-head studies on the choice of topical and systemic therapies for moderate to severe AD in the pediatric age group.